Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pulmonary artery banding.

Antonio F Corno1

  • 1Alder Hey Royal Children Hospital, University of Liverpool, England, UK. Antonio.Corno@rlc.nhs.uk

Swiss Medical Weekly
|December 3, 2005
PubMed
Summary
This summary is machine-generated.

Adjustable pulmonary artery banding using the FloWatch device offers a less invasive approach for congenital heart defects. This innovative banding reduces complications and shortens hospital stays for pediatric patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Age- and sex-specific reference intervals for anti-Müllerian hormone during childhood in Chinese population: a cross-sectional study of 2,450 healthy children.

Translational pediatrics·2025
Same author

Meta-analysis on sex differences in mortality and neurodevelopment in congenital heart defects.

Scientific reports·2025
Same author

The role of teamwork and mentorship in pediatric and congenital heart surgery.

Translational pediatrics·2024
Same author

Is the social media creating an anxious youth?-international call for action.

Translational pediatrics·2024
Same author

Beyond borders: an appraisal of the global congenital cardiac surgery workforce.

Translational pediatrics·2024
Same author

Assisted reproduction and congenital malformations: A systematic review and meta-analysis.

Congenital anomalies·2024
Same journal

Metamizole-induced agranulocytosis: utilisation trends, pharmacovigilance signals and regulatory risk-minimisation in Switzerland.

Swiss medical weekly·2026
Same journal

Female genital mutilation/cutting and risk of obstetric anal sphincter injury at delivery.

Swiss medical weekly·2026
Same journal

Drug prescription before and after implementation of a CPOE system on the Paediatric Intensive Care Unit: a quality improvement study.

Swiss medical weekly·2026
Same journal

Trends in health- and lifestyle-related aspects in women of childbearing age: analysis of Swiss Health Survey data between 1992 and 2022.

Swiss medical weekly·2026
Same journal

Microplastics in the air and potential health risks - a narrative review.

Swiss medical weekly·2026
Same journal

Potentially inappropriate medication: prevalence, risk of hospitalisation and associated healthcare costs in the general older population of Switzerland.

Swiss medical weekly·2026
See all related articles

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Surgery
  • Biomedical Engineering

Background:

  • Pulmonary artery banding is a palliative treatment for complex congenital heart defects.
  • Conventional banding presents challenges including optimal tightness, age-related variability, and need for reoperation.
  • Existing methods struggle with precise control and require frequent adjustments.

Purpose of the Study:

  • To evaluate the clinical efficacy of a novel telemetrically controlled adjustable pulmonary artery banding device (FloWatch).
  • To assess the impact of FloWatch on patient management and outcomes compared to traditional banding.
  • To explore potential for expanded applications in congenital heart defect treatment.

Main Methods:

  • Clinical testing of the wireless, battery-free, implantable FloWatch device.

Related Experiment Videos

  • Remote, telemetric control for progressive occlusion and reopening of the pulmonary artery band.
  • Comparison of outcomes with conventional pulmonary artery banding techniques.

    • Main Results:

    • FloWatch allows precise, adjustable banding without reoperation.
    • Significant reduction in mortality and morbidity associated with banding.
    • Substantial shortening of intensive care unit and hospital stays.
    • Successful clinical application following animal studies.

    Conclusions:

    • The FloWatch device offers a significant advancement in managing increased pulmonary artery blood flow and pressure.
    • Adjustable pulmonary artery banding improves patient outcomes and resource utilization.
    • This technology holds promise for broader application in pediatric cardiovascular surgery.